Seres Therapeutics (MCRB) stock

Market cap $19.7MShares as of Aug 3

$1.98

-5.26%

As of Monday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score MCRB. It is too small and too thinly traded for a fair Quality Score.

Healthcare · Biotech

Cash$15.6M in cash. One of the last four quarters brought cash in while the others used it.On Jun 30 · raised money since, not counted · the company says “through the first quarter of 2027”

Follow MCRB's news. Pro members can get an alert when Seres Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when MCRB files newsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,191 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$15.6M in cash. One of the last four quarters brought cash in while the others used it.On Jun 30 · raised money since, not counted · the company says “through the first quarter of 2027”

What's next for MCRB, and how long its cash lasts

Cash runway Jun 30 balance sheet

$15.6M in cash

One of the last four quarters brought cash in while the others used it, so an average says little about the next.

What it means: a runway is counted only when each of the last four quarters used cash. The company's estimate is “through the first quarter of 2027” (8-K, Aug 5). It has raised money since that balance sheet, which is not counted here.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed Aug 13, 2026)
At-the-market share sales program (S-3, filed Aug 13, 2026)

For Pro members: 1 raise and its amount, and the share count against a year ago.

Insiders

An officer, Kelly Brady, sold 64 shares on Aug 17, under a planned sale. 11 more insider trades this year.

From Form 4: open-market buys and sales only.

Get an alert when Eric Shaff buys or sells

For Pro members: every trade, and Eric Shaff’s 11 filings and quotes.

Get an alert when MCRB files newsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 15 daysANDA decisionIn 15 days · ANDA decisionNRXPNRX PharmaceuticalsPreservative-free ketamineNRXPNRX Pharmaceuticals · $104MPreservative-free ketamineA generic, under FDA review (GDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $356MDeramiocelFDA decision due (PDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $933MMolgramostimFDA decision due (PDUFA)

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 168 dates, ranked →

MCRB's latest filings

A change of officers or directors8-K, filed Oct 26
4 insider filingsForm 4, filed Aug 18
Shelf registration, to sell securities laterS-3, filed Aug 13

23 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why MCRB isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. MCRB is worth about $19.7M and trades about 78,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.